Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2010
05/06/2010US20100113467 Organic Compounds
05/06/2010US20100113466 Oxazole-pyridazine-oxazole alpha-helix mimetic
05/06/2010US20100113447 Triazole compounds that modulate hsp90 activity
05/06/2010US20100113445 Chemical Compounds
05/06/2010US20100113440 Pyrimidine substituted macrocyclic hcv inhibitors
05/06/2010US20100113424 N-benzyl pyrrolidine derivatives
05/06/2010US20100113414 Thiazolyl-dihydro-indazoles
05/06/2010US20100113413 MAPK/ERK Kinase Inhibitors
05/06/2010US20100112584 Cyanine compounds and their use in staining biological samples
05/06/2010US20100111858 Diangostic and Therapeutic Cyclooxygenase-2 Binding Ligands
05/06/2010CA2742007A1 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
05/06/2010CA2741988A1 7-hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same
05/06/2010CA2741606A1 Novel salts of sunitinib
05/06/2010CA2738776A1 7-azaspiro [3.5] nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase
05/06/2010CA2714958A1 1,3 imidazolidine derivatives and their use in the production of carbapenem
05/05/2010EP2181992A1 Polycyclic compound
05/05/2010EP2181991A1 Novel salts of sunitinib
05/05/2010EP2181985A1 Antiviral Agent
05/05/2010EP2181108A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
05/05/2010EP2181092A1 1,3-dihydroisoindole derivatives
05/05/2010EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases
05/05/2010EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors
05/05/2010CN1930157B Silylierte carboxamide
05/05/2010CN1878767B Azole-based kinase inhibitors
05/05/2010CN1702067B Method of preparing N,N'-carbonyl diazole
05/05/2010CN1666983B Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest contollers and a method for using the same
05/05/2010CN101702907A Piperazine compounds with a herbicidal action
05/05/2010CN101702905A Functionally selective alpha 2C adrenoreceptor agonists
05/04/2010US7709660 Polymethine ether compounds
05/04/2010US7709655 Clickphosphines for transition metal-catalyzed reactions
05/04/2010US7709637 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi
05/04/2010US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis
05/04/2010US7709493 Tryptophan hydroxylase inhibitors; anticarcinogenic agents; gastrointestinal, cardiovascular, and respiratory system disorders; (S)-2-amino-3-[4-(2-amino-6-{R-1-[4-chloro-2-(3-methyl-pyrazol-1-yl)-phenyl]-2,2,2-trifluoro-ethoxy}-pyrimidin-4-yl)-phenyl]-propionic acid ethyl ester
05/04/2010US7709489 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2-a]quinoline-2-carbonyl)-4-methylpiperazine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives
05/04/2010US7709487 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
05/04/2010US7709486 antiviral compounds 1,4,8,11-tetraazacyclotetradecane derivatives for against HIV-infected cells, to inhibit the binding by the natural ligand to its chemokine receptor; viricides
05/04/2010US7709484 1-((2R,5S)-5-Benzyl-2-naphthalen-2-ylmethyl-piperazin-1-yl)-3-(2,4-dichloro-phenyl)-propan-1-one; melanocortin receptor-associated disorder such as cachexia, obesity, erectile dysfunction or female sexual dysfunction
05/04/2010US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer
05/04/2010US7709479 Quinazoline derivatives and their use as pharmaceuticals
05/04/2010US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
05/04/2010US7709477 Triheterocyclic Compounds; small cell lung cancer, follicular lymphoma, non-small cell lung cancer, non-Hodgkin's disease lymphoma, or acute myelocytic leukemia
05/04/2010US7709473 5-[2-(6-tert-Butyl-3-oxo-2,3-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-ylamino)-ethoxy]-nicotinic acid methyl ester; inhibitors of glycogen synthase kinase 3 (GSK-3); diabetes, dementia, Alzheimer's Disease, bipolar disorder, stroke, schizophrenia, depression, hair loss, cancer
05/04/2010US7709469 purinergic receptor inhibitors; 5-[2-chloro-3-(trifluoromethyl)phenyl]-1-[2,3-dihydro-1H-inden-1-yl]-1H-1,2,4-triazole; [4-(2,3-Dichloro-phenyl)-4H-[1,2,4]triazol-3-yl]-(2-pyrrolidin-1-yl-pyridin-3-ylmethyl)-amine
05/04/2010US7709466 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals
05/04/2010CA2439001C Water-soluble triazole antifungal agents
05/04/2010CA2437767C Heterocyclic inhibitors of erk2 and uses thereof
05/04/2010CA2385817C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
04/2010
04/29/2010WO2010047372A1 2-aminopyridin-4-one and 2-aminopyridine derivative both having bace1-inhibiting activity
04/29/2010WO2010047369A1 Agent for treatment of diabetic nephropathy
04/29/2010WO2010046804A2 A process for preparation of losartan potassium form i
04/29/2010WO2010046780A2 Anti viral compounds
04/29/2010WO2010020432A3 Compounds for treatment of duchenne muscular dystrophy
04/29/2010WO2010008828A3 Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds
04/29/2010US20100105907 Continuous antisolvent crystallization process and system using plug flow reactors
04/29/2010US20100105904 Urea type cinnamide derivative
04/29/2010US20100105896 Pharmaceutical compounds
04/29/2010US20100105894 Cyclopropane compounds and pharmaceutical use thereof
04/29/2010US20100105729 Aryl-substituted heterocyclic pde4 inhibitors as anti-inflammatory agents
04/29/2010US20100105726 Imidazole derivatives that induce apoptosis and their therapeutic uses
04/29/2010US20100105712 Chemical compounds
04/29/2010US20100105703 Synthetic Mimetics Of Host Defense And Uses Thereof
04/29/2010US20100105702 Heterocyclylethylamide derivatives
04/29/2010US20100105701 Gyrase inhibitors and uses thereof
04/29/2010US20100105694 Substituted pyrazinone derivatives for use as a medicine
04/29/2010US20100105684 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
04/29/2010US20100105683 Compounds useful for inhibiting chk1
04/29/2010US20100105674 Chemical Compounds
04/29/2010US20100105665 Renin inhibitors
04/29/2010US20100105663 2-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitors
04/29/2010US20100105659 2-aminopyridine analogs as glucokinase activators
04/29/2010US20100105655 Novel compounds 515
04/29/2010US20100105654 Substituted quinazolinone compounds
04/29/2010US20100104659 Benzopyranopyrazoles
04/28/2010EP2180020A1 Indolium compound and optical recording material using the compound
04/28/2010EP2178863A1 Process for synthesizing compounds useful for treating hepatitis c
04/28/2010EP2178862A1 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri)
04/28/2010EP2178860A1 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri)
04/28/2010EP2029547B1 Fxr agonists
04/28/2010EP1907366B1 New imidazole derivatives, preparation method thereof and organic electronic device using the same
04/28/2010EP1838699B1 Method for production of candesartan
04/28/2010EP1643989B1 Cis-imidazolines as mdm2 inhibitors
04/28/2010EP1363640B1 Nucleic acid derivatives
04/28/2010CN1832939B Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
04/27/2010US7705149 Benzoimidazole compounds
04/27/2010US7705143 Benzoimidazole compounds
04/27/2010US7705031 Benzimidazoles useful as modulators of ion channels
04/27/2010US7705030 2-Amino-5-[3-(2fluoropyridin-3-yl)phenyl]-3methyl-5-[3-methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]-3,5-dihydro-4H-imidazol-4-one; Alzheimer's disease, cognitive impairment, Down's Syndrome, senile dementia, cerebral amyloid angiopathy, neurofibrillary tangles, beta -amyloid deposits
04/27/2010US7705029 Acrylonitrile derivatives for inflammation and immune-related uses
04/27/2010US7705026 Biaryl heterocyclic compounds and methods of making and using the same
04/27/2010US7705020 Benzimidazolone carboxylic acid derivatives
04/27/2010US7705019 Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors
04/27/2010US7705007 Cis-imidazolines
04/27/2010US7705006 Anti-cancer cyclopenta[g]quinazoline compounds
04/27/2010US7704998 Sulfonyl-derivatives as novel inhibitors or histone deacetylase
04/27/2010US7704997 Amino-tetrazole analogues and methods of use
04/27/2010US7704996 Compounds and compositions useful as cathepsin S inhibitors
04/27/2010US7704995 Protein kinase modulators and methods of use
04/27/2010US7704994 1-{6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3- pyridinyl}-2-pyrrolidinone and salts; histamine H3 antagonists; Alzheimer's disease; schizophrena; antiepileptic agents; analgesics; neuropathic pain; Parkinson's disease; attention deficit disorder
04/27/2010CA2563042C 4-2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
04/27/2010CA2495880C Pyrimidine derivatives and their use as cb2 modulators
1 ... 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 ... 626